Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals

Journal of Nutritional Biochemistry

Volumn 20, Issue 11, 2009, Pages 901-908

  Qin, Bolin ^a,d   Polansky, Marilyn M ^a   Sato, Yuzo ^b   Adeli, Khosrow ^c   Anderson, Richard A ^a  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Integrity Nutraceuticals International   (United States)

Author keywords

Cinnamon Extract; Intestinal Insulin Signaling; Postprandial apob 48

Indexed keywords

APOLIPOPROTEIN B48; CINNAMON EXTRACT; CINNULIN; FRUCTOSE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LIPOPROTEIN; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OLIVE OIL; PROTEIN KINASE B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG MECHANISM; EX VIVO STUDY; GENE EXPRESSION; INSULIN SENSITIVITY; INTESTINE CELL; LIPOPROTEIN METABOLISM; MALE; MOLECULAR MECHANICS; NONHUMAN; POSTPRANDIAL STATE; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMAL FEED; ANIMALS; APOLIPOPROTEIN B-48; CARRIER PROTEINS; CHOLESTEROL; CINNAMOMUM ZEYLANICUM; CRICETINAE; DIETARY CARBOHYDRATES; ENTEROCYTES; FRUCTOSE; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MESOCRICETUS; PLANT EXTRACTS; POSTPRANDIAL PERIOD; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

ANIMALIA; CINNAMOMUM VERUM; CRICETINAE; RATTUS;

EID: 71749102085     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.08.005     Document Type: Article

References (41)

1. Cohn J.S. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol 14 Suppl B (1998) 18B-27B
2. Sniderman A.D. Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspective. Eur J Clin Invest 30 (2000) 935-937
3. Zilversmit D.B. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 41 (1995) 153-158
4. Kolovou G.D., Anagnostopoulou K.K., Daskalopoulou S.S., Mikhailidis D.P., and Cokkinos D.V. Clinical relevance of postprandial lipaemia. Curr Med Chem 12 (1995) 1931-1945
5. Doi H., Kugiyama K., Ohgushi M., Sugiyama S., Matsumura T., Ohta Y., et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis 137 (1998) 341-349
6. Mero N., Malmstrom R., Steiner G., Taskinen M.R., and Syvanne M. Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 150 (2000) 167-177
7. Adeli K., Taghibiglou C., Van Iderstine S.C., and Lewis G.F. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 11 (2001) 170-176
8. Carpentier A., Taghibiglou C., Leung N., Szeto L., Van Iderstine S.C., Uffelman K.D., et al. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277 (2002) 28795-28802
9. Haidari M., Leung N., Mahbub F., Uffelman K.D., Kohen-Avramoglu R., Lewis G.F., et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277 (2002) 31646-31655
10. Lewis G.F., Naples M., Uffelman K., Leung N., Szeto L., and Adeli K. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters. Endocrinology 145 (2004) 5006-5012
11. Zoltowska M., Ziv E., Delvin E., Sinnett D., Kalman R., Garofalo C., et al. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 52 (2003) 2539-2545
12. Zheng C., Ikewaki K., Walsh B.W., and Sacks F.M. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. J Lipid Res 47 (2006) 1771-1779
13. Welty F.K., Lichtenstein A.H., Barrett P.H., Dolnikowski G.G., and Schaefer E.J. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol 19 (1999) 2966-2974
14. Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., and Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 62 (2003) 139-148
15. Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., and Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res 36 (2004) 119-125
16. Broadhurst C.L., Polansky M.M., and Anderson R.A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 48 (2000) 849-852
17. Anderson R.A., Broadhurst C.L., Polansky M.M., Schmidt W.F., Khan A., Flanagan V.P., et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52 (2004) 65-70
18. Imparl-Radosevich J., Deas S., Polansky M.M., Baedke D.A., Ingebritsen T.S., Anderson R.A., et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res 50 (1998) 177-182
19. Jarvill-Taylor K.J., Anderson R.A., and Graves D.J. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 20 (2001) 327-336
20. Ziegenfuss T.N., Hofheins J.E., Mendel R.W., Landis J., and Anderson R.A. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3 (2006) 45-53
21. Roussel A.M., Hininger I., Benaraba R., Ziegenfuss T.N., and Anderson R.A. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr (2008) [in press]
22. Wang J.G., Anderson R.A., Graham III G.M., Chu M.C., Sauer M.V., Guarnaccia M.M., et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril 88 (2007) 240-243
23. Mang B., Wolters M., Schmitt B., Kelb K., Lichtinghagen R., Stichtenoth D.O., et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36 (2006) 340-344
24. Khan A., Safdar M., li Khan M.M., Khattak K.N., and Anderson R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26 (2003) 3215-3218
25. Kannappan S., Jayaraman T., Rajasekar P., Ravichandran M.K., and Anuradha C.V. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J 47 (2006) 858-863
26. Lee J.S., Jeon S.M., Park E.M., Huh T.L., Kwon O.S., Lee M.K., et al. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats. J Med Food 6 (2003) 183-191
27. Subash B.P., Prabuseenivasan S., and Ignacimuthu S. Cinnamaldehyde - a potential antidiabetic agent. Phytomedicine 14 (2007) 15-22
28. Goulinet S., and Chapman M.J. Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB-and apoA-I-containing particles. J Lipid Res 34 (1993) 943-959
29. Hoang V.Q., Pearce N.J., Suckling K.E., and Botham K.M. Evaluation of cultured hamster hepatocytes as an experimental model for the study of very low density lipoprotein secretion. Biochim Biophys Acta 1254 (1995) 37-44
30. Federico L.M., Naples M., Taylor D., and Adeli K. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes 55 (2006) 1316-1326
31. Qin B., Qiu W., Avramoglu R.K., and Adeli K. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes 56 (2007) 450-461
32. Wetterau J.R., Lin M.C., and Jamil H. Microsomal triglyceride transfer protein. Biochim Biophys Acta 1345 (1997) 136-150
33. Foufelle F., and Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 366 (2002) 377-391
34. Arbeeny C.M., Meyers D.S., Bergquist K.E., and Gregg R.E. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res 33 (1992) 843-851
35. Lewis G.F., Uffelman K., Naples M., Szeto L., Haidari M., and Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 146 (2005) 247-255
36. Phillips C., Owens D., Collins P., and Tomkin G.H. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?. Atherosclerosis 160 (2002) 355-360
37. Phillips C., Bennett A., Anderton K., Owens D., Collins P., White D., et al. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism 51 (2002) 847-852
38. Gleeson A., Anderton K., Owens D., Bennett A., Collins P., Johnson A., et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42 (1999) 944-948
39. Hagan D.L., Kienzle B., Jamil H., and Hariharan N. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J Biol Chem 269 (1994) 28737-28744
40. Wang S.L., Du E.Z., Martin T.D., and Davis R.A. Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1. J Biol Chem 272 (1997) 19351-19358
41. Nagai Y., Nishio Y., Nakamura T., Maegawa H., Kikkawa R., and Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am J Physiol Endocrinol Metab 282 (2002) E1180-E1190